Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Tsumura & Co ( (JP:4540) ) has provided an update.
Tsumura & Co. clarified that recent reports in the digital and print editions of The Nikkei about its involvement in a potential take-private transaction for Yomeishu Seizo Co., Ltd. did not originate from the company itself. The company acknowledged that it is considering the reported matters but emphasized that no decisions have been made, and it pledged to disclose any material developments in a timely and appropriate manner, signaling that discussions remain at a preliminary stage and that stakeholders should not assume a finalized deal.
The most recent analyst rating on (JP:4540) stock is a Hold with a Yen4584.00 price target. To see the full list of analyst forecasts on Tsumura & Co stock, see the JP:4540 Stock Forecast page.
More about Tsumura & Co
Tsumura & Co. is a Japan-based pharmaceutical company listed on the Tokyo Stock Exchange Prime Market, best known for manufacturing and marketing Kampo (traditional Japanese herbal) medicines and related products for the domestic and overseas healthcare markets.
Average Trading Volume: 361,050
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen312.4B
Find detailed analytics on 4540 stock on TipRanks’ Stock Analysis page.